These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 4831006)

  • 1. The behavior of isotope labelled blood proteins in thrombosis.
    Strachan CJ; Scully MF; Kakkar VV
    Thromb Res; 1974 Feb; 4(2):303-18. PubMed ID: 4831006
    [No Abstract]   [Full Text] [Related]  

  • 2. Metabolic fate of urokinase.
    Tajima H; Ishiguro J; Nonaka R; Kurita M; Tanaka S
    Chem Pharm Bull (Tokyo); 1974 Apr; 22(4):727-35. PubMed ID: 4418203
    [No Abstract]   [Full Text] [Related]  

  • 3. The in vivo behavior of the terminal derivatives of fibrinogen and fibrin cleaved by plasmin.
    Catanzaro A; Edgington TS
    J Lab Clin Med; 1974 Mar; 83(3):458-66. PubMed ID: 4272970
    [No Abstract]   [Full Text] [Related]  

  • 4. Digestion of fibrin by thrombin.
    Triantaphyllopoulos DC; Chandra S
    Biochim Biophys Acta; 1973 Nov; 328(1):229-32. PubMed ID: 4271567
    [No Abstract]   [Full Text] [Related]  

  • 5. Isolation of a low molecular weight form of plasminogen.
    Paoni NF; Castellino FJ
    Biochem Biophys Res Commun; 1975 Jul; 65(2):757-64. PubMed ID: 125089
    [No Abstract]   [Full Text] [Related]  

  • 6. Fibrinogen responses following thrombosis.
    Farrell GW
    Bibl Anat; 1973; 12():279-85. PubMed ID: 4790362
    [No Abstract]   [Full Text] [Related]  

  • 7. Fibrinolysis associated with oncogenic transformation. Partial purification and characterization of the cell factor, a plasminogen activator.
    Unkeless J; Dano K; Kellerman GM; Reich E
    J Biol Chem; 1974 Jul; 249(13):4295-305. PubMed ID: 4368727
    [No Abstract]   [Full Text] [Related]  

  • 8. [Behavior of 125-I-fibrinogen and 131-I-albumin in experimental galactosamine hepatitis].
    von Mahn I; Merkel H; Sattler EL; Müller-Berghaus G
    Verh Dtsch Ges Inn Med; 1974; 80():437-9. PubMed ID: 4454578
    [No Abstract]   [Full Text] [Related]  

  • 9. Molecular composition and biological properties of soluble fibrin polymers encountered in thrombotic states.
    Bang NU; Hansen MS; Smith GF; Latallo ZS; Chang ML; Mattler LE
    Ser Haematol; 1973; 6(4):494-512. PubMed ID: 4277578
    [No Abstract]   [Full Text] [Related]  

  • 10. Physicochemical and biological properties of human and canine plasmins.
    Takeda Y; Nakabayashi M
    J Clin Invest; 1974 Jan; 53(1):154-62. PubMed ID: 4128408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Nuclear medical thrombosis diagnosis, current state and developmental trends].
    Endert G; Eger H; Kleinert P; Klose E
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1975; 102(2):157-62. PubMed ID: 50979
    [No Abstract]   [Full Text] [Related]  

  • 12. The role of sialic acid in the determination of distinct properties of the isozymes of rabbit plasminogen.
    Siefring GE; Castellino FJ
    J Biol Chem; 1974 Dec; 249(24):7742-6. PubMed ID: 4430672
    [No Abstract]   [Full Text] [Related]  

  • 13. Incorporation of radiolabelled fibrinogen into venous thrombi induced in dogs.
    Kravis TC; Shibel EM; Brooks JD; Moser KM
    Circulation; 1974 Jan; 49(1):158-64. PubMed ID: 4808836
    [No Abstract]   [Full Text] [Related]  

  • 14. [Features of the interaction of Glu- and Lys-forms of plasminogen with native and partially hydrolyzed fibrin].
    Grinenko TV; Skomorovskaia EV; Kudinov SA; Zolotareva EN
    Biokhimiia; 1992 May; 57(5):728-37. PubMed ID: 1322196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The course and prerequisites of Lys-plasminogen formation during fibrinolysis.
    Suenson E; Thorsen S
    Biochemistry; 1988 Apr; 27(7):2435-43. PubMed ID: 3382632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein metabolism following injury.
    Davies JW
    J Clin Pathol Suppl (R Coll Pathol); 1970; 4():56-64. PubMed ID: 4123923
    [No Abstract]   [Full Text] [Related]  

  • 17. Cross-linking of salmon fibrinogen and fibrin by factor XIII and transglutaminase.
    Murtaugh PA; Halver JE; Gladner JA
    Biochem Biophys Res Commun; 1973 Oct; 54(3):849-55. PubMed ID: 4148128
    [No Abstract]   [Full Text] [Related]  

  • 18. Dysfibrinogenemia (fibrinogen Dusard) associated with impaired fibrin-enhanced plasminogen activation.
    Lijnen HR; Soria J; Soria C; Collen D; Caen JP
    Thromb Haemost; 1984 Feb; 51(1):108-9. PubMed ID: 6539000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibrinogen turnover after massive haemorrhage in dogs studied with radioactively labelled fibrinogen.
    Leandoer L; Appelgren L; Bergentz SE
    Acta Chir Scand; 1968; 134(7):517-24. PubMed ID: 5731293
    [No Abstract]   [Full Text] [Related]  

  • 20. The short-term measurement of plasma protein catabolic rates.
    Zalin AM; Carson E; Black EG; Hoffenberg R
    J Nucl Biol Med; 1972; 16(2):73-80. PubMed ID: 4575657
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.